Unicycive Therapeutics, Inc. (17) | Intellectual Property (2)

Browse by Subcategory

License Agreements (2)

Recent Contracts

License Agreement effective as of July 14, 2022 by and between Unicycive Therapeutics, Inc. and Lees Pharmaceutical (HK) Limited (Filed With SEC on July 18, 2022)
Exclusive License Agreement by and between the Company and Sphaera Pharma Pte. Ltd., dated October 1, 2017 (Filed With SEC on June 7, 2021)